A novel RyR2 mutation in a 2-year-old baby presenting with atrial fibrillation, atrial flutter, and atrial ectopic tachycardia.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Heart Rhythm

• Publication date

  2014-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.hrthm.2014.04.037PMID 24793461
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Suppression of Spontaneous Ca Elevations Prevents Atrial Fibrillation in Calsequestrin 2-Null Hearts

  2014cited by this paper
• Abnormal Ca2+ homeostasis, atrial arrhythmogenesis, and sinus node dysfunction in murine hearts modeling RyR2 modification

  2013cited by this paper
• Flecainide reduces Ca2+ spark and wave frequency via inhibition of the sarcolemmal sodium current

  2013cited by this paper
• A novel mutation in the RYR2 gene leading to catecholaminergic polymorphic ventricular tachycardia and paroxysmal atrial fibrillation: dose-dependent arrhythmia-event suppression by β-blocker therapy.

  2011cited by this paper
• Flecainide therapy reduces exercise-induced ventricular arrhythmias in patients with catecholaminergic polymorphic ventricular tachycardia.

  2011cited by this paper
• Short Communication: Flecainide Exerts an Antiarrhythmic Effect in a Mouse Model of Catecholaminergic Polymorphic Ventricular Tachycardia by Increasing the Threshold for Triggered Activity

  2011cited by this paper
• Flecainide inhibits arrhythmogenic Ca2+ waves by open state block of ryanodine receptor Ca2+ release channels and reduction of Ca2+ spark mass.

  2010cited by this paper
• The RYR2-encoded ryanodine receptor/calcium release channel in patients diagnosed previously with either catecholaminergic polymorphic ventricular tachycardia or genotype negative, exercise-induced long QT syndrome: a comprehensive open reading frame mutational analysis.

  2009cited by this paper
• Sudden Death in a Young Man with Catecholaminergic Polymorphic Ventricular Tachycardia and Paroxysmal Atrial Fibrillation

  2008cited by this paper
• Association of atrial arrhythmia and sinus node dysfunction in patients with catecholaminergic polymorphic ventricular tachycardia.

  2007cited by this paper
• Defective Cardiac Ryanodine Receptor Regulation During Atrial Fibrillation

  2005cited by this paper
• Clinical and Molecular Characterization of Patients With Catecholaminergic Polymorphic Ventricular Tachycardia

  2002cited by this paper
• Mutations in the Cardiac Ryanodine Receptor Gene (hRyR2) Underlie Catecholaminergic Polymorphic Ventricular Tachycardia

  2001cited by this paper
• Mutations of the Cardiac Ryanodine Receptor (RyR2) Gene in Familial Polymorphic Ventricular Tachycardia

  2001cited by this paper
• Catecholaminergic polymorphic ventricular tachycardia in children. A 7-year follow-up of 21 patients.

  1995cited by this paper
• Ectopic automatic atrial tachycardia in children: clinical characteristics, management and follow-up.

  1988cited by this paper

• Calcium‐mediated DAD in membrane potentials and triggered activity in atrial myocytes of ETV1f / fMyHCCre /+ mice

  2024cites this paper
• RYR2 receptor gene mutation associated with catecholaminergic polymorphic ventricular tachycardia in children: a case report & literature review

  2024cites this paper
• 2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS).

  2024cites this paper
• RYR2-ryanodinopathies: from calcium overload to calcium deficiency

  2023cites this paper
• The Role of RYR2 in Atrial Fibrillation

  2023cites this paper
• Atrial fibrillation: epigenetic aspects and role of sodium-glucose cotransporter 2 inhibitors.

  2022cites this paper
• 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)

  2021cites this paper
• Identification of loss-of-function RyR2 mutations associated with idiopathic ventricular fibrillation and sudden death

  2021cites this paper
• Genetics and Epigenetics of Atrial Fibrillation

  2020cites this paper
• Intracellular calcium leak in heart failure and atrial fibrillation: a unifying mechanism and therapeutic target

  2020cites this paper
• Genetics Of Atrial Fibrilation: In Search Of Novel Therapeutic Targets.

  2019cites this paper
• A calcium transport mechanism for atrial fibrillation in Tbx5-mutant mice

  2019cites this paper
• Identification of Central Regulators of Calcium Signaling and ECM–Receptor Interaction Genetically Associated With the Progression and Recurrence of Atrial Fibrillation

  2018cites this paper
• Catecholaminergic Polymorphic Ventricular Tachycardia.

  2017cites this paper
• The Complexity of Pediatric Multifocal Atrial Tachycardia and Its Prognostic Factors

  2017cites this paper
• Cardiac aging and heart disease in humans

  2017cites this paper
• Genomics of Atrial Fibrillation

  2016cites this paper
• Slowed depolarization and irregular repolarization in catecholaminergic polymorphic ventricular tachycardia: a study from cellular Ca2+ transients and action potentials to clinical monophasic action potentials and electrocardiography.

  2016cites this paper
• Atrial fibrillation in inherited cardiac channelopathies: From mechanisms to management.

  2016cites this paper
• Transient left ventricular dysfunction during fever-induced Brugada-like electrocardiographic pattern.

  2016cites this paper
• Enhanced Cytosolic Ca2+ Activation Underlies a Common Defect of Central Domain Cardiac Ryanodine Receptor Mutations Linked to Arrhythmias*

  2016influential citation
• Catecholaminergic Polymorphic Ventricular Tachycardia.

  2016cites this paper
• Arrhythmia-Induced Cardiomyopathies

  2015cites this paper
• The RyR2-P2328S mutation downregulates Nav1.5 producing arrhythmic substrate in murine ventricles

  2015cites this paper
• Mitochondrial oxidative stress promotes atrial fibrillation

  2015cites this paper
• Arrhythmia-Induced Cardiomyopathies: Mechanisms, Recognition, and Management.

  2015cites this paper
• Sinus node dysfunction in catecholaminergic polymorphic ventricular tachycardia: risk factor and potential therapeutic target?

  2014cites this paper
• 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS): Supplementary Data

  year unknowncites this paper